首页> 外文期刊>Circulation journal >Optimal Medical Therapy vs. Percutaneous Coronary Intervention for Patients With Coronary Chronic Total Occlusion – A Propensity-Matched Analysis –
【24h】

Optimal Medical Therapy vs. Percutaneous Coronary Intervention for Patients With Coronary Chronic Total Occlusion – A Propensity-Matched Analysis –

机译:冠状动脉慢性完全闭塞患者的最佳药物治疗与经皮冠状动脉介入治疗–倾向匹配分析–

获取原文
           

摘要

Background: Limited data are available on the long-term clinical outcomes of coronary chronic total occlusion (CTO) patients who receive optimal medical therapy (OMT) compared with percutaneous coronary intervention (PCI). Methods?and?Results: Between March 2003 and February 2012, 2,024 patients with CTO were enrolled in a single-center registry. Among this patient group, we excluded CTO patients who underwent coronary artery bypass grafting and classified patients into the OMT group (n=664) or PCI group (n=883) according to initial treatment strategy. Propensity-score matching was also performed. The primary outcome was cardiac death. The median follow-up duration was 45.8 (interquartile range: 22.8–71.1) months. In the PCI group, 699 patients (79.2%) underwent successful revascularization. In the propensity-score matched population (533 pairs), there was no significant difference in the rate of cardiac death between the OMT and PCI groups (hazard ratio, 1.57; 95% confidence interval, 0.91–2.72, P=0.11). In the subgroup analysis, there were no significant interactions between the PCI strategy and cardiac death among several subgroups except that regarding collateral flow grades 0–2 vs. those with grade 3 (P=0.01). Conclusions: As an initial treatment strategy, PCI did not reduce cardiac death compared with OMT for the treatment of CTO in the drug-eluting stent era. ( Circ J 2016; 80: 211–217)
机译:背景:与经皮冠状动脉介入治疗(PCI)相比,接受最佳药物治疗(OMT)的冠状动脉慢性完全闭塞(CTO)患者的长期临床结局资料有限。方法和结果:在2003年3月至2012年2月之间,将2024名CTO患者纳入单中心登记册。在该患者组中,我们排除了行冠状动脉搭桥术的CTO患者,并根据初始治疗策略将其分为OMT组(n = 664)或PCI组(n = 883)。还进行了倾向得分匹配。主要结果是心脏死亡。中位随访时间为45.8(四分位间距:22.8-71.1)个月。在PCI组中,有699例患者(79.2%)成功进行了血运重建。在倾向得分匹配的人群(533对)中,OMT组和PCI组之间的​​心源性死亡率没有显着差异(危险比,1.57; 95%置信区间,0.91-2.72,P = 0.11)。在亚组分析中,几个亚组之间的PCI策略和心源性死亡之间没有显着的相互作用,除了0至2级的侧支血流与3级的侧支血流有关(P = 0.01)。结论:在药物洗脱支架时代,作为一种初步的治疗策略,与使用OMT进行CTO相比,PCI没有减少心源性死亡。 (Circ J 2016; 80:211–217)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号